The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Gastrointestinal flora and gastrointestinal status in children with autism – comparisons to typical children and correlation with autism severity
Open accessAbstract
BACKGROUND: Children with autism have often been reported to have gastrointestinal problems that are more frequent and more severe than in children from the general population. METHODS: Gastrointestinal flora and gastrointestinal status were assessed from stool samples of 58 children with Autism Spectrum Disorders (ASD) and 39 healthy typical children of similar ages. Stool testing included bacterial and yeast culture tests, lysozyme, lactoferrin, secretory IgA, elastase, digestion markers, short chain fatty acids (SCFA's), pH, and blood presence. Gastrointestinal symptoms were assessed with a modified six-item GI Severity Index (6-GSI) questionnaire, and autistic symptoms were assessed with the Autism Treatment Evaluation Checklist (ATEC). RESULTS: Gastrointestinal symptoms (assessed by the 6-GSI) were strongly correlated with the severity of autism (assessed by the ATEC), (r = 0.59, p < 0.001). Children with 6-GSI scores above 3 had much higher ATEC Total scores than those with 6-GSI-scores of 3 or lower (81.5 +/- 28 vs. 49.0 +/- 21, p = 0.00002).Children with autism had much lower levels of total short chain fatty acids (-27%, p = 0.00002), including lower levels of acetate, proprionate, and valerate; this difference was greater in the children with autism taking probiotics, but also significant in those not taking probiotics. Children with autism had lower levels of species of Bifidobacter (-43%, p = 0.002) and higher levels of species of Lactobacillus (+100%, p = 0.00002), but similar levels of other bacteria and yeast using standard culture growth-based techniques. Lysozyme was somewhat lower in children with autism (-27%, p = 0.04), possibly associated with probiotic usage. Other markers of digestive function were similar in both groups. CONCLUSIONS: The strong correlation of gastrointestinal symptoms with autism severity indicates that children with more severe autism are likely to have more severe gastrointestinal symptoms and vice versa. It is possible that autism symptoms are exacerbated or even partially due to the underlying gastrointestinal problems. The low level of SCFA's was partly associated with increased probiotic use, and probably partly due to either lower production (less sacchrolytic fermentation by beneficial bacteria and/or lower intake of soluble fiber) and/or greater absorption into the body (due to longer transit time and/or increased gut permeability).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Several studies found lower levels of fecal SCFA, including butyrate in feces of ASD children [53, 64], while a 2012 study found increased ammonia and SCFA including acetic, butyric, isobutyric, valeric, and isovaleric acids in ASD [61].”
From The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders (2018) · cites this paper as [53]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the order Lactobacillales and family Streptococcaceae, Streptococcus results (not S. thermophilus) corroborated an overall decrease in counts and percentage in ASD cases when statistical significance was reached [30, 31, 33, 37, 41].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“however, upon a closer look at Bifidobacterium, consistently lower counts and proportions were found in children with ASD versus their siblings [31, 52] or controls [30, 38, 47].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, ASD patients seem to be characterized by both elevated levels of SCFA concentrations in stool and serum, and increased level of SCFA-producing bacteria (e.g., Clostridia, Desulfovibrio, and Bacteroides) [29,36,180].”
From Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions (2019) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, has been reported that the severity of gastrointestinal disorders in children with ASD may be closely linked to the intensity of neuropsychiatric symptoms, with more severe GI issues observed in individuals with more pronounced neuropsychiatric symptoms, and vice versa [33,34].”
From The Prevalence and Clinical Significance of Toe Walking in Autism Spectrum Disorder: A Cross-Sectional Study in an Italian Pediatric Sample (2025) · cites this paper as [33]
17 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091 · cited 2×
“Decreased levels may reflect insufficient normal colonic flora, a diet low in soluble fiber, or prolonged intestinal transit time [ 39 ].”
BackgroundPyrosequencing study of fecal microflora of autistic and control children
Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., Youn, E., Summanen, P. H., Granpeesheh, D., Dixon, D., et al. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2010.06.008 · Cited by 977 · cited 4×
“Feingold’s pyrosequencing study [14] estimated that typical children normally have about 500-600 species of bacteria in their gut and estimated that children with autism have about twice that, so it is important to remember that we are only able to culture a small fraction of the species present.”
BackgroundMethodResultInfluentialNutritional and physiologic significance of human milk proteins
Lönnerdal, B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.6.1537s · Cited by 878 · cited 1×
“Infants fed formula without lysozyme have three times the rate of diarrheal disease [43].”
BackgroundParracho, H. M., Bingham, M. O., Gibson, G. R., & McCartney, A. L. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46101-0 · Cited by 784 · cited 2×
“Parracho et al. 2005 [13] used another culture-independent technique, fluorescence in situ hybridization (FISH) targeting Clostridium groups, and reported differences in the gut microflora of children with ASD compared to healthy children.”
BackgroundMethodGastrointestinal Microflora Studies in Late‐Onset Autism
Finegold, S. M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M., Bolte, E., McTeague, M., Sandler, R., Wexler, H., Marlowe, E. M., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/341914 · Cited by 742 · cited 2×
“Finegold et al. 2002 [11] studied fecal samples from 13 children with late-onset autism and 8 controls.”
BackgroundShort-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500701 · Cited by 614 · cited 2×
“Additionally Desulfovibrio species and Bacteroides vulgatus were present in higher numbers in autistic than controls Treatment studies using a minimally absorbed oral antibiotic (vancomycin) to treat abnormal gut flora showed significant temporary improvements in behavior for children with late-onset autism [15], but…”
BackgroundReal-Time PCR Quantitation of Clostridia in Feces of Autistic Children
Song, Y., Liu, C., & Finegold, S. M. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.11.6459-6465.2004 · Cited by 556
de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., et al. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181dcc4a5 · Cited by 546
MACFABE, D., CAIN, D., RODRIGUEZCAPOTE, K., FRANKLIN, A., HOFFMAN, J., BOON, F., TAYLOR, A., KAVALIERS, M., & OSSENKOPP, K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.025 · Cited by 497 · cited 3×
“2007 [17], which demonstrates that SCFA’s can induce autistic-like symptoms when injected into rats.”
BackgroundVolatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
Garner, C. E., Smith, S., de Lacy Costello, B., White, P., Spencer, R., Probert, C. S. J., & Ratcliffem, N. M. (2007) · The FASEB Journal · doi:10.1096/fj.06-6927com · Cited by 439
Research works printed but not linked: 4
- Rimland B, Edelson S: Autism Treatment Evaluation Checklist: Statistical Analyses. 2000, Autism Research Institute, San Diego, CA
- Dugad L: Performance Verification of Lysozyme ELISA Test Kit Verification 105. 2007, Doctor's Data, Inc. Saint Charles, Illinois
- Dugad L, Wu Z: PerformanceVerification of Lactoferrin ELISA Test Kit of Fecal Verification 104. 2007, Doctor's Data Inc, Saint Charles, Illinois
- Edelson S: Parent Ratings of Behavioral Effects of Biomedical Interventions. 2010, Autism Research Institute, Publication 34, San Diego, CA
Cited by
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
“…obesity, and cardiovascular disease (Blumberg and Powrie, 2012), and several studies report altered composition of the intestinal microbiota in ASD (Adams et al., 2011; Finegold et al., 2010; Finegold et al., 2012; Kang et al., 2013; Parracho et al., 2005; Williams et al., 2011; Williams et al.,…”
InfluentialMicrobiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
“demonstrated that symptoms of GI discomfort were correlated with severity of autism in children.(265) A small pilot scale study conducted by Kang et al.”
BackgroundThe Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043
“Although Sharon and coworkers did not evaluate the alteration in SCFAs, children with ASD have been previously reported to have both lower (144) and higher (33) fecal SCFA levels than controls.”
Background
Metadata
- Authors
- Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A.
- Affiliations
- Arizona State University (US)
- Whittier College (US)
- Corresponding author
- Adams, James B
- ORCID
- Adams, James B
- Venue
- BMC Gastroenterology
- Published
- 2011-03-16
- Volume
- 11
- Issue
- 1
- Pages
- 22-22
- ISSN
- 1471-230X (ISSN-L)
- PMC
- PMC3072352
- OpenAlex
- W1996441448
- Cited by
- 1,076
- References
- 40
- Citations by year
- 2026: 42 · 2025: 76 · 2024: 92 · 2023: 85 · 2022: 100 · 2021: 101 · 2020: 104 · 2019: 99 · 2018: 81 · 2017: 58 · 2016: 59 · 2015: 60 · 2014: 43 · 2013: 38 · 2012: 25
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- BMC Gastroenterology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Arizona State University Library Digital Repository (Arizona State University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Autism Research Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- autism spectrum disorder, gastrointestinal symptoms, gut microbiota, short-chain fatty acids, probiotics, Lactobacillus, lysozyme, lactoferrin, secretory IgA, autism severity, children, dysbiosis, dietary fiber, yeast overgrowth, Autism Treatment Evaluation Checklist, stool examination
- MeSH terms
- Autistic Disorder, Bifidobacterium, Child, Child, Preschool, Digestion, Fatty Acids, Volatile, Female, Gastrointestinal Diseases, Humans, Lactobacillus, Male, Severity of Illness Index, Case-Control Studies, Probiotics, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gastrointestinal flora and gastrointestinal status in children with autism – comparisons to typical children and correlation with autism severity. https://app.cochat.ai/papers/10.1186/1471-230x-11-22
- The paper
- Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011). Gastrointestinal flora and gastrointestinal status in children with autism – comparisons to typical children and correlation with autism severity. BMC Gastroenterology. https://doi.org/10.1186/1471-230x-11-22
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.